These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16966277)

  • 1. Down-regulation of wt1 expression in leukemia cell lines as part of apoptotic effect in arsenic treatment using two compounds.
    Glienke W; Chow KU; Bauer N; Bergmann L
    Leuk Lymphoma; 2006 Aug; 47(8):1629-38. PubMed ID: 16966277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of arsenic trioxide on viability, proliferation, and apoptosis in human megakaryocytic leukemia cell lines.
    Lu M; Levin J; Sulpice E; Sequeira-Le Grand A; Alemany M; Caen JP; Han ZC
    Exp Hematol; 1999 May; 27(5):845-52. PubMed ID: 10340400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of arsenic trioxide (As2O3) on leukemic cells from patients with non-M3 acute myelogenous leukemia: studies of cytotoxicity, apoptosis and the pattern of resistance.
    Lehmann S; Bengtzen S; Paul A; Christensson B; Paul C
    Eur J Haematol; 2001 Jun; 66(6):357-64. PubMed ID: 11488934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium arsenite induces apoptosis and Epstein-Barr virus reactivation in lymphoblastoid cells.
    Zebboudj A; Maroui MA; Dutrieux J; Touil-Boukoffa C; Bourouba M; Chelbi-Alix MK; Nisole S
    Biochimie; 2014 Dec; 107 Pt B():247-56. PubMed ID: 25241256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose 1,25-dihydroxyvitamin D(3) combined with arsenic trioxide synergistically inhibits proliferation of acute myeloid leukemia cells by promoting apoptosis.
    Bae JY; Kim JW; Kim I
    Oncol Rep; 2013 Jul; 30(1):485-91. PubMed ID: 23660868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of arsenic trioxide (As2O3) on human megakaryocytic leukemia cell lines. With a comparison of its effects on other cell lineages.
    Alemany M; Levin J
    Leuk Lymphoma; 2000 Jun; 38(1-2):153-63. PubMed ID: 10811458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenic trioxide induces apoptosis in leukemia/lymphoma cell lines via the CD95/CD95L system.
    Zhu J; Okumura H; Ohtake S; Nakamura S; Nakao S
    Oncol Rep; 2003; 10(3):705-9. PubMed ID: 12684647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose arsenic trioxide combined with aclacinomycin A synergistically enhances the cytotoxic effect on human acute myelogenous leukemia cell lines by induction of apoptosis.
    Ye Y; Xu X; Zhang M; Qiu D; Bai X; Wang J; Weng G; Zhou R; Guo Z; He H; Yi W; He X; Guo K
    Leuk Lymphoma; 2015; 56(11):3159-67. PubMed ID: 25739941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of four arsenic antagonists on apoptosis and telomerase activity induced by arsenic trioxide in three myelocytic leukemia cell lines.
    Wei YM; Ou YX; Bai H; Lu JH; Zheng RL
    Acta Pharmacol Sin; 2001 Aug; 22(8):725-30. PubMed ID: 11749846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of intracellular arsenic trioxide for therapeutic response in acute promyelocytic leukemia.
    Sahu GR; Jena RK
    Am J Hematol; 2005 Feb; 78(2):113-6. PubMed ID: 15682419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of expression of aquaglyceroporin 9 with arsenic uptake and sensitivity in leukemia cells.
    Leung J; Pang A; Yuen WH; Kwong YL; Tse EW
    Blood; 2007 Jan; 109(2):740-6. PubMed ID: 16968895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphological and biochemical changes induced by arsenic trioxide in neuroblastoma cell lines.
    Ryu KH; Woo SY; Lee MY; Jung YJ; Yoo ES; Seoh JY; Kie JH; Shin HY; Ahn HS
    Pediatr Hematol Oncol; 2005; 22(7):609-21. PubMed ID: 16166054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic-induced apoptosis in malignant cells in vitro.
    Akao Y; Yamada H; Nakagawa Y
    Leuk Lymphoma; 2000 Mar; 37(1-2):53-63. PubMed ID: 10721769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of Arsenic Trioxide on Cdc20 and Mad2 in Acute Myeloid Leukemia HL-60 Cell Line].
    Ding SM; Xu RR; Kan JY; Wang Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Jun; 26(3):710-715. PubMed ID: 29950208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic trioxide induces not only apoptosis but also autophagic cell death in leukemia cell lines via up-regulation of Beclin-1.
    Qian W; Liu J; Jin J; Ni W; Xu W
    Leuk Res; 2007 Mar; 31(3):329-39. PubMed ID: 16882451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic trioxide inhibits DNA methyltransferase and restores TMS1 gene expression in K562 cells.
    Li H; Wang Y; Xu W; Dong L; Guo Y; Bi K; Zhu C
    Acta Haematol; 2015; 133(1):18-25. PubMed ID: 24993472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide: acute promyelocytic leukemia and beyond.
    Bachleitner-Hofmann T; Kees M; Gisslinger H
    Leuk Lymphoma; 2002 Aug; 43(8):1535-40. PubMed ID: 12400595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preliminary study on the arsenic trioxide-induced NB4 cell apoptosis and its molecular mechanisms].
    Chen G; Zhu J; Shi X; Zhong H; Liu W; Jin X; Tang W; Li X; Ni J; Xiong S; Shen Z; Ma J; Zhang P; Zhang T; Claude G; Chen S; Chen L; Wang Z
    Zhonghua Xue Ye Xue Za Zhi; 1997 Jan; 18(1):25-8. PubMed ID: 15622746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual effects of arsenic trioxide (As2O3) on non-acute promyelocytic leukaemia myeloid cell lines: induction of apoptosis and inhibition of proliferation.
    Rojewski MT; Baldus C; Knauf W; Thiel E; Schrezenmeier H
    Br J Haematol; 2002 Mar; 116(3):555-63. PubMed ID: 11849211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenylarsine oxide (PAO) more intensely induces apoptosis in acute promyelocytic leukemia and As2O3-resistant APL cell lines than As2O3 by activating the mitochondrial pathway.
    Sahara N; Takeshita A; Kobayashi M; Shigeno K; Nakamura S; Shinjo K; Naito K; Maekawa M; Horii T; Ohnishi K; Kitamura K; Naoe T; Hayash H; Ohno R
    Leuk Lymphoma; 2004 May; 45(5):987-95. PubMed ID: 15291359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.